glucosamine has been researched along with crx-526 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bielefeldt-Ohmann, H; Correia, Jda S; Crane, RT; Fling, SP; Fort, MM; Hershberg, RM; Jeffery, E; Johnson, DA; Mozaffarian, A; Persing, DH; Probst, P; Stöver, AG; Ulevitch, RJ | 1 |
| Arnold, JS; Bazin, HG; Bess, LS; Bowen, WS; Cluff, CW; Evans, JT; Fling, SP; Johnson, CL; Johnson, DA; Livesay, MT; Mozaffarian, A; Murray, TJ; Ryter, KT | 1 |
| Abano, JB; Berlin, H; Burridge, K; Casiraghi, M; Egan, TM; Funkhouser, WK; Randell, SH; Sevala, M; Smyth, S; Tatreau, JR; Zanotti, G | 1 |
| Chan, LY; Lai, KN; Leung, JC; Li, RX; Lin, M; Tang, SC; Wong, DW; Wu, HJ; Yiu, WH | 1 |
| Cao, CB; Huang, HY; Liu, FF; Peng, JQ; Qian, J; Ren, XJ; Wang, N; Zhang, ZJ | 1 |
| Johnston, B; Lehmann, C; Pavlovic, D; Soltow, M; Zhou, J; Zimmermann, K | 1 |
| Akinbobuyi, B; Chang, CA; Kane, RR; Naziruddin, B; Quintana, JM; Yoshimatsu, G | 1 |
7 other study(ies) available for glucosamine and crx-526
| Article | Year |
|---|---|
A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caproates; Cells, Cultured; Colitis; Dextran Sulfate; Disease Models, Animal; Female; Glucosamine; HeLa Cells; Humans; Inflammatory Bowel Diseases; Lipid A; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Knockout; Monocytes; Receptors, Immunologic; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2005 |
The 'Ethereal' nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics.
Topics: Animals; Chemistry, Pharmaceutical; Drug Design; Glucosamine; Glycolipids; Humans; Inhibitory Concentration 50; Lipid A; Lipids; Mice; Models, Biological; Models, Chemical; Monocytes; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2008 |
Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema.
Topics: Actins; Animals; Cytoskeleton; Endothelial Cells; Enzyme Activation; Glucosamine; Humans; Ligands; Lung; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Paracrine Communication; Pulmonary Edema; Reperfusion Injury; Toll-Like Receptor 4; Warm Ischemia | 2009 |
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Topics: Albuminuria; Animals; Blood Glucose; Blood Urea Nitrogen; Chemokine CCL2; Chemokine CCL5; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Glucosamine; HMGB1 Protein; Kidney; Macrophages; Mice; Mice, Knockout; NF-kappa B; Nitric Oxide Synthase Type III; Osteopontin; Streptozocin; Time Factors; Toll-Like Receptor 4; Transforming Growth Factor beta | 2013 |
The TLR4/NF-κB signaling pathway mediates the growth of colon cancer.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Female; Glucosamine; Humans; Male; Mice; Mice, Nude; NF-kappa B; Random Allocation; Signal Transduction; Toll-Like Receptor 4; Xenograft Model Antitumor Assays | 2014 |
Experimental TLR4 inhibition improves intestinal microcirculation in endotoxemic rats.
Topics: Animals; Capillaries; Cell Adhesion; Cytokines; Disease Models, Animal; Endotoxemia; Glucosamine; Gram-Negative Bacteria; Inflammation; Intestines; Intravital Microscopy; Leukocytes; Lipopolysaccharides; Male; Microcirculation; Perfusion; Rats; Rats, Inbred Lew; Sepsis; Toll-Like Receptor 4 | 2015 |
Ex-vivo generation of drug-eluting islets improves transplant outcomes by inhibiting TLR4-Mediated NFkB upregulation.
Topics: Animals; Cell Line, Tumor; Cell Survival; Diabetes Mellitus; Glucosamine; Inflammation; Islets of Langerhans; Islets of Langerhans Transplantation; Lipid A; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Sulfonamides; Toll-Like Receptor 4 | 2018 |